Effects of AT1 receptor antagonist therapy in patients with severe heart failure pretreated with angiotensin-converting enzyme inhibitors

about

Effects of AT1 receptor antagonist therapy in patients with severe heart failure pretreated with angiotensin-converting enzyme inhibitors

Item

http://www.wikidata.org/entity/Q37278552

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2002

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of AT1 receptor antago ...... n-converting enzyme inhibitors

@en

Effects of AT1 receptor antago ...... -converting enzyme inhibitors.

@nl

type

Item

label

Effects of AT1 receptor antago ...... n-converting enzyme inhibitors

@en

Effects of AT1 receptor antago ...... -converting enzyme inhibitors.

@nl

prefLabel

Effects of AT1 receptor antago ...... n-converting enzyme inhibitors

@en

Effects of AT1 receptor antago ...... -converting enzyme inhibitors.

@nl

P1476

Effects of AT1 receptor antago ...... n-converting enzyme inhibitors

@en

P2093

Bernhard Gremmler

http://www.w3.org/2001/XMLSchema#string

Heinrich Schleiting

http://www.w3.org/2001/XMLSchema#string

Klaus Kisters

http://www.w3.org/2001/XMLSchema#string

Ludger J Ulbricht

http://www.w3.org/2001/XMLSchema#string

Matthias Kunert

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

Cardiac protection: evolving role of angiotensin receptor blockers.

Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers.

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Neurohumoral blockade in CHF management.

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

[Cardioprotective effects by ramipril after ischemia and reperfusion in animal experiment studies]

Role of the angiotensin II receptor blocker valsartan in heart failure.

P304

193-198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19644591

http://www.w3.org/2001/XMLSchema#string

P932

2716991

http://www.w3.org/2001/XMLSchema#string